ArticleEuropean heart journal2014

Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation.

Paul Dorian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.